These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 9723252)

  • 1. Cyclosporine: the principal immunosuppressant for renal transplantation.
    Keown PA; Primmett DR
    Transplant Proc; 1998 Aug; 30(5):1712-5. PubMed ID: 9723252
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
    Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
    Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and effectiveness of microemulsion cyclosporine in renal allograft recipients: 1-year follow-up study.
    Park K; Kim MS; Kim SI; Kim YS; Moon JI
    Transplant Proc; 1998 Nov; 30(7):3556-7. PubMed ID: 9838557
    [No Abstract]   [Full Text] [Related]  

  • 4. Tacrolimus and ciclosporin microemulsion in renal transplantation.
    Schieppati A; Perico N; Remuzzi G
    Lancet; 2002 Sep; 360(9335):799-800, author reply 800-1. PubMed ID: 12241845
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoral versus Sandimmune in kidney transplantation.
    Tisone G; Orlando G; Mercadante E; Vennarecci G; Pisani F; Buonomo O; Negrini S; Casciani CU
    Transplant Proc; 1998 Aug; 30(5):1749-50. PubMed ID: 9723265
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrolimus and ciclosporin microemulsion in renal transplantation.
    Emovon OE; Browne BJ
    Lancet; 2002 Sep; 360(9335):799; author reply 800-1. PubMed ID: 12241844
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of tacrolimus on the outcome of renal transplantation with donor-specific blood transfusion.
    Miura S; Okazaki H; Sato T; Amada N; Ohashi Y
    Transplant Proc; 1998 Jun; 30(4):1212-3. PubMed ID: 9636492
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary analysis of a randomized trial comparing microemulsion cyclosporine and tacrolimus for recipients of renal transplants from non-heart-beating donors.
    Williams ST; Knight AL; White SA; Doughman TM; Nicholson ML
    Transplant Proc; 2000 Feb; 32(1):196. PubMed ID: 10701022
    [No Abstract]   [Full Text] [Related]  

  • 9. One-center comparison between primary immunosuppression based on neoral cyclosporine and tacrolimus for renal transplantation.
    Pascual J; Marcén R; Burgos FJ; Tenorio MT; Merino JL; Arambarri M; Villafruela JJ; Liaño F; Mampaso F; Ortuño J
    Transplant Proc; 2002 Feb; 34(1):94-5. PubMed ID: 11959200
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative induction therapy with oral cyclosporine for recipients of living-related renal transplants.
    Rudich SM; Bhaduri S; Chang T; Cahn J; Katznelson S; Perez RV
    Transplant Proc; 1998 Jun; 30(4):1339-42. PubMed ID: 9636545
    [No Abstract]   [Full Text] [Related]  

  • 11. Pregnancy outcomes in female renal transplant recipients.
    Armenti VT; McGrory CH; Cater JR; Radomski JS; Moritz MJ
    Transplant Proc; 1998 Aug; 30(5):1732-4. PubMed ID: 9723259
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
    Dudley CR;
    Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression.
    Mirza DF; Gunson BK; Soonawalla Z; Pirenne J; Mayer AD; Buckels JA; McMaster P
    Lancet; 1997 Mar; 349(9053):701-2. PubMed ID: 9078209
    [No Abstract]   [Full Text] [Related]  

  • 14. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
    Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR
    Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
    [No Abstract]   [Full Text] [Related]  

  • 15. A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
    Foradori A; Pinto VM; Elberg A
    Transplant Proc; 1998 Aug; 30(5):1666-7. PubMed ID: 9723235
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L; Wang Y; Fu SJ; Cheng XJ
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal transplantation with Simulect (basiliximab) plus Sandimmune Neoral-based immunosuppression: a report of 41 cases in Taiwan.
    Tsai MK; Chu SH; Hu RH; Chiang YJ; Chueh SC; Lai MK; Lee PH
    Transplant Proc; 2001; 33(7-8):3194. PubMed ID: 11750369
    [No Abstract]   [Full Text] [Related]  

  • 18. Neoral reduces the incidence of acute rejection after renal transplantation.
    Sandrini S; Setti G; Gaggia P; Chiappini R; Maffeis R; Tardanico R; Maiorca R
    Transplant Proc; 1998 Aug; 30(5):1758-9. PubMed ID: 9723269
    [No Abstract]   [Full Text] [Related]  

  • 19. Steroid withdrawal in renal transplant recipients.
    Oppenheimer F
    Transplant Proc; 2000 Feb; 32(1A Suppl):14S-15S. PubMed ID: 10686314
    [No Abstract]   [Full Text] [Related]  

  • 20. Trial of steroid withdrawal in renal transplant recipients with long-term--surviving allograft.
    Mizuno Y; Kikuchi H; Fujimori K; Doi H; Orii T; Ohkohchi N; Satomi S
    Transplant Proc; 2000 Nov; 32(7):1677-8. PubMed ID: 11119888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.